Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Tax liability | -$2.63M | -62K | -14.96% | $42.38 | 352K | Feb 22, 2023 | Direct | F1 |
holding | PFE | Common Stock | 4.28K | Feb 22, 2023 | By Rule 16b-3 Plan |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | Award | $0 | +413K | $0.00 | 413K | Feb 23, 2023 | Common Stock | 413K | $42.30 | Direct | F2 | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +360K | $0.00 | 360K | Feb 23, 2023 | Common Stock | 360K | $42.30 | Direct | F3 |
Id | Content |
---|---|
F1 | The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon). |
F2 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
F3 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |